PRF Technologies (PRFX) Accumulated Expenses (2019 - 2025)
PRF Technologies' (PRFX) quarterly Accumulated Expenses came in at $1.9 million in Q4 2025, down 1.89% YoY from $1.9 million in Q4 2024, and up 2.02% on a QoQ basis from $1.8 million in Q2 2025.
PRF Technologies (PRFX) Accumulated Expenses (2019 - 2025) Analysis & Trends
PRF Technologies (PRFX) has 7 years of Accumulated Expenses data on file, last reported at $1.9 million in Q4 2025.
- Quarterly Accumulated Expenses fell 1.89% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (down 1.89% YoY) and the FY2025 annual result came in at $1.9 million, down 1.89% from the prior year.
- Accumulated Expenses improved to $1.9 million in Q4 2025, from $1.8 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $4.3 million in Q2 2024 to a low of $53000.0 in Q2 2022.
- A 5-year average of $998294.1 and a median of $499000.0 in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses sank 90.47% — and 2024, when it surged 1513.56%.
- Tracing PRFX's Accumulated Expenses over 5 years: stood at $423000.0 in 2021, then grew by 17.97% to $499000.0 in 2022, then slumped by 76.35% to $118000.0 in 2023, then surged by 1513.56% to $1.9 million in 2024, then fell by 1.89% to $1.9 million in 2025.
- The last three Accumulated Expenses figures came in at $1.9 million (Q4 2025), $1.8 million (Q2 2025), and $1.9 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | PRF Technologies | 654,452.72 | -3.49 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Jun 30, 2024 | 4.28 Mn |
| Mar 31, 2024 | 2.47 Mn |
| Dec 31, 2023 | 118,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 525,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 499,000.00 |
| Sep 30, 2022 | 395,000.00 |
| Jun 30, 2022 | 53,000.00 |
| Mar 31, 2022 | 121,000.00 |
| Dec 31, 2021 | 423,000.00 |
| Sep 30, 2021 | 457,000.00 |
| Jun 30, 2021 | 556,000.00 |
| Mar 31, 2021 | 582,000.00 |
| Dec 31, 2020 | 149,000.00 |
| Dec 31, 2019 | 151,000.00 |